New Zealand markets open in 56 minutes

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9300+0.1400 (+5.02%)
At close: 04:00PM EDT
2.9000 -0.03 (-1.02%)
After hours: 04:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 411.16M
Enterprise value 163.53M
Trailing P/E 43.96
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.37
Price/book (mrq)1.33
Enterprise value/revenue 0.96
Enterprise value/EBITDA -0.86

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3-56.61%
S&P500 52-week change 323.57%
52-week high 39.0800
52-week low 32.2800
50-day moving average 33.1751
200-day moving average 34.6700

Share statistics

Avg vol (3-month) 31.73M
Avg vol (10-day) 31.85M
Shares outstanding 5147.37M
Implied shares outstanding 6147.37M
Float 897.57M
% held by insiders 12.79%
% held by institutions 194.12%
Shares short (15 Apr 2024) 410.01M
Short ratio (15 Apr 2024) 45.28
Short % of float (15 Apr 2024) 48.85%
Short % of shares outstanding (15 Apr 2024) 46.90%
Shares short (prior month 15 Mar 2024) 48.46M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -132.28%
Operating margin (ttm)-99.68%

Management effectiveness

Return on assets (ttm)-16.60%
Return on equity (ttm)-58.34%

Income statement

Revenue (ttm)170.28M
Revenue per share (ttm)1.18
Quarterly revenue growth (yoy)-17.10%
Gross profit (ttm)N/A
EBITDA -179.38M
Net income avi to common (ttm)-225.25M
Diluted EPS (ttm)-1.5600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)346.4M
Total cash per share (mrq)2.39
Total debt (mrq)229.43M
Total debt/equity (mrq)74.42%
Current ratio (mrq)4.66
Book value per share (mrq)2.13

Cash flow statement

Operating cash flow (ttm)-156.32M
Levered free cash flow (ttm)-81.95M